U.S. Government Awards Novavax $1.6 billion For Coronavirus Vaccine
The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021
Novavax…